Stress Evaluation and Management Using High Fidelity Simulation in Medical Education
STRATAGEM
The Role of High-fidelity Medical Simulation in Managing Emotional Components and Stress During Emergency and Urgent Care
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
The goal of this interventional study is to collect clinical and neurophysiological information to determine whether high-fidelity simulation can serve as a stress-inducing stimulus in a population of healthy residents (Emergency medicine, Anesthesia and Intensive care medicine, Paediatrics), both male and female, aged between 25 and 40 years. The main questions it aims to answer are:
- During the simulation, automatic pupillometry will be performed on all team members at the four time points.
- Additionally, a two-lead ECG will be recorded for all team members at baseline and end of the debriefing
- One team member will undergo EEG monitoring throughout the entire simulation. The EEG recordings will be sampled at baseline, during the simulation and end of the debriefing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedFirst Posted
Study publicly available on registry
April 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedApril 8, 2025
January 1, 2025
Same day
February 11, 2025
April 1, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Heart Rate Variability (HRV) Analysis in the time domain
To assess whether stress levels vary during simulation phases. All subjects will undergo electrocardiographic (ECG) recording at baseline and at the end of the debriefing using a portable Holter ECG device. The ECG traces will then be extracted, artifact-cleaned, and converted for Heart Rate Variability (HRV) analysis using dedicated software. HRV is a measure of the variation in R-R intervals between consecutive heartbeats and reflects the extrinsic regulation of heart rate mediated by the autonomic nervous system on the sinoatrial node.
From the enrolment to two weeks after
Heart rate variability (HRV) analysis in the frequency domain
Low frequency (LF) reflects the simultaneous influence of both sympathetic and parasympathetic control on the sinoatrial node; and high frequency (HF) reflects parasympathetic nervous system modulation. The LF/HF ratio will be calculated as an indicator of the sympathovagal balance.
from the enrolment to two weeks after
Secondary Outcomes (3)
Changes in autonomic parameters in response to stress induced by high-fidelity simulation: automatic pupillometry.
From the enrolment to two weeks after
Identify brain areas involved during simulation using EEG
From the enrolment to two weeks after
Variation of stress level over time using Perceived Stress Scale 10
From the enrolment to two weeks after
Study Arms (1)
Simulation team
EXPERIMENTALAll participants will be divided in teams, each one consisting of three medical trainees from the same specialty training program, and all of them will undergo two high-fidelity simulations based on a clinical scenario relevant to their specialization.
Interventions
During the simulation, automatic pupillometry will be performed on all team members at the following time points: Baseline (T0) During the simulation (T1) End of the simulation (T2) End of the debriefing (T3)
EEG monitoring throughout the entire simulation. The EEG recordings will be sampled at: Baseline (T0) During the simulation (T1) End of the debriefing (T2)
Eligibility Criteria
You may qualify if:
- Medical trainees from the specialties of Emergency Medicine, Anesthesia and Intensive Care, Clinical Toxicology, Pediatrics, and Neonatology.
- Normal hearing and vision, or corrected to normal.
You may not qualify if:
- Known history of psychiatric disorders, cognitive impairment, or cardiac arrhythmias.
- Current treatment with psychoactive, cardio-stimulant, or cardio-inhibitory medications.
- Significant stressful life events in the past six months (e.g., family bereavement).
- Previous systematic experience in meditation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Champeroux P, Fesler P, Jude S, Richard S, Le Guennec JY, Thireau J. High-frequency autonomic modulation: a new model for analysis of autonomic cardiac control. Br J Pharmacol. 2018 Aug;175(15):3131-3143. doi: 10.1111/bph.14354. Epub 2018 Jun 15.
PMID: 29723392BACKGROUNDNiskanen JP, Tarvainen MP, Ranta-Aho PO, Karjalainen PA. Software for advanced HRV analysis. Comput Methods Programs Biomed. 2004 Oct;76(1):73-81. doi: 10.1016/j.cmpb.2004.03.004.
PMID: 15313543BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Gullì
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2025
First Posted
April 8, 2025
Study Start
April 1, 2025
Primary Completion
April 1, 2025
Study Completion
May 1, 2025
Last Updated
April 8, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Beginning 3 months and ending 3 years after the publication of results
- Access Criteria
- All researchers that wish to, can gain access to the IPD and supporting information by contacting the corresponding author
All IPD collected throughout the trial